CHERYL LYNN JAEGER
CHERYL LYNN JAEGER is named as a lobbyist in 28 lobbying reports we hold, filed by 1 registrant for 28 clients.
Earlier government jobs, as reported
A lobbying report lists each lobbyist's covered positions: jobs in Congress or the executive branch that the law asks a lobbyist to disclose. Each line is copied as a report states it.
No report we hold lists a covered position for CHERYL LYNN JAEGER.
Registrants and clients
- CROSSROADS STRATEGIES, LLC · 28 reports
Clients: 3M COMPANY; ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED); ALABAMA INSTITUTE FOR DEAF AND BLIND; ALKERMES, INC.; ALTRIA CLIENT SERVICES LLC; AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE; BLINK HEALTH, INC.; BROAD INSTITUTE; CENTERSTONE; COCA-COLA BOTTLING COMPANY UNITED, INC.; EISAI, INC.; EPILEPSY FOUNDATION OF AMERICA; GINKGO BIOWORKS, INC.; HALEON US HOLDINGS LLC; KIDNEY CARE PARTNERS; KLASKO IMMIGRATION LAW PARTNERS, LLP ON BEHALF OF INTEALTH; LIFESCIENCE LOGISTICS; MADRIGAL PHARMACEUTICALS, INC.; MARSH MCLENNAN; MERCK & CO., INC.; NATIONAL MULTIPLE SCLEROSIS SOCIETY; PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA; PROTON THERAPY CONSORTIUM; RESEARCH!AMERICA; SANOFI US SERVICES INC.; TAKEDA PHARMACEUTICALS AMERICA, INC.; THE BOEING COMPANY; VERTEX PHARMACEUTICALS INCORPORATED.
Bills named where this lobbyist is listed, and how the House and the Senate voted
37 bills named in these reports. 1 of them became law, and our record holds how the House and the Senate voted on it. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14. | Became law | Public Law 119-21House 218–214 · Senate 50–50 |
| H.R. 1189National Plan for Epilepsy Act | Introduced | No recorded vote in our record |
| H.R. 1227Alternatives to PAIN Act | Introduced | No recorded vote in our record |
| H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. | Introduced | No recorded vote in our record |
| H.R. 2314FAIR Act | Introduced | No recorded vote in our record |
| H.R. 3885Community TEAMS Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 5343Ensuring Patient Access to Critical Breakthrough Products Act | Introduced | No recorded vote in our record |
| H.R. 6214Kidney Care Access Protection Act | Introduced | No recorded vote in our record |
| H.R. 7567Farm, Food, and National Security Act of 2026 | Passed the House | No recorded vote in our record |
| H.R. 8495Financial Services and General Government Appropriations Act, 2027 | Introduced | No recorded vote in our record |
| H.R. 8594Congressional Gold Medal For Inspiring Great Heroism and Tenacity (FIGHT) Act | Introduced | No recorded vote in our record |
| H.R. 8595Making appropriations for national security, Department of State, and related programs for the fiscal year ending September 30, 2027, and for other purposes. | Passed the House | No recorded vote in our record |
| H.R. 8646Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 | Passed the House | No recorded vote in our record |
| H.R. 8800National Defense Authorization Act for Fiscal Year 2027 | Passed the House | No recorded vote in our record |
| H.R. 8845Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 | Introduced | No recorded vote in our record |
| H.R. 8875Improving Home Dialysis Act of 2026 | Introduced | No recorded vote in our record |
| H.R. 9170Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027 | Introduced | No recorded vote in our record |
| H.R. 9260Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 | Introduced | No recorded vote in our record |
| H.R. 9310Department of Homeland Security Appropriations Act, 2027 | Introduced | No recorded vote in our record |
| H.R. 9495Department of Defense Appropriations Act, 2027 | Introduced | No recorded vote in our record |
| S. 475Alternatives to PAIN Act | Introduced | No recorded vote in our record |
| S. 494National Plan for Epilepsy Act | Passed the Senate | No recorded vote in our record |
| S. 527Prescription Pricing for the People Act of 2025 | Reported by committee | No recorded vote in our record |
| S. 832EPIC Act of 2025 | Introduced | No recorded vote in our record |
| S. 891Bipartisan Health Care Act | Introduced | No recorded vote in our record |
| S. 1040Drug Competition Enhancement Act | Reported by committee | No recorded vote in our record |
| S. 1041Affordable Prescriptions for Patients Act | Passed the Senate | No recorded vote in our record |
| S. 1095Stop STALLING Act | Reported by committee | No recorded vote in our record |
| S. 1096Preserve Access to Affordable Generics and Biosimilars Act | Reported by committee | No recorded vote in our record |
| S. 1097Interagency Patent Coordination and Improvement Act of 2025 | Reported by committee | No recorded vote in our record |
| S. 2658Medication Affordability and Patent Integrity Act | Reported by committee | No recorded vote in our record |
| S. 2715FAIR Act of 2025 | Introduced | No recorded vote in our record |
| S. 2730Kidney Care Access Protection Act | Introduced | No recorded vote in our record |
| S. 3014Ensuring Timely Access to Generics Act of 2025 | Introduced | No recorded vote in our record |
| S. 3989Community TEAMS Act of 2026 | Introduced | No recorded vote in our record |
| S. 4750Semiconductor Superiority Act | Introduced | No recorded vote in our record |
| S. 4784National Defense Authorization Act for Fiscal Year 2027 | Reported by committee | No recorded vote in our record |
Issues named: Health Issues (17), Medicare/Medicaid (12), Taxation/Internal Revenue Code (9), Trade (domestic/foreign) (9), Budget/Appropriations (8), Medical/Disease Research/Clinical Labs (5), Copyright/Patent/Trademark (4), Defense (2), Environment/Superfund (2), Pharmacy (2), Science/Technology (2), Agriculture (1), and 6 mores.
Every report
| Client | Registrant | Kind, as filed | Posted | Report |
|---|---|---|---|---|
| 3M COMPANYEnvironment/Superfund, Consumer Issues/Safety/Products, Taxation/Internal Revenue Code, Trade (domestic/foreign) | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED)Health Issues, Medicare/Medicaid, Trade (domestic/foreign), Budget/Appropriations, Defense | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| SANOFI US SERVICES INC.Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign), Health Issues, Taxation/Internal Revenue Code, Budget/Appropriations | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| PROTON THERAPY CONSORTIUMMedicare/Medicaid | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| NATIONAL MULTIPLE SCLEROSIS SOCIETYHealth Issues, Medicare/Medicaid, Taxation/Internal Revenue Code | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| MARSH MCLENNANHealth Issues | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| MADRIGAL PHARMACEUTICALS, INC.Medicare/Medicaid, Health Issues | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| LIFESCIENCE LOGISTICSBudget/Appropriations, Medical/Disease Research/Clinical Labs, Health Issues | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| HALEON US HOLDINGS LLCHealth Issues, Taxation/Internal Revenue Code, Budget/Appropriations, Trade (domestic/foreign), Medicare/Medicaid | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| GINKGO BIOWORKS, INC.Medical/Disease Research/Clinical Labs | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| EPILEPSY FOUNDATION OF AMERICAHealth Issues, Taxation/Internal Revenue Code | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| COCA-COLA BOTTLING COMPANY UNITED, INC.Agriculture, Beverage Industry | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| CENTERSTONEHealth Issues | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAHealth Issues, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign) | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| BLINK HEALTH, INC.Pharmacy | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINEHealth Issues | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| ALTRIA CLIENT SERVICES LLCBudget/Appropriations, Tobacco, Government Issues, Taxation/Internal Revenue Code | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| ALKERMES, INC.Pharmacy | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| ALABAMA INSTITUTE FOR DEAF AND BLINDBudget/Appropriations | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| THE BOEING COMPANYEnvironment/Superfund | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| TAKEDA PHARMACEUTICALS AMERICA, INC.Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark, Trade (domestic/foreign) | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| RESEARCH!AMERICABudget/Appropriations, Medical/Disease Research/Clinical Labs, Science/Technology | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| MERCK & CO., INC.Trade (domestic/foreign), Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| KIDNEY CARE PARTNERSHealth Issues, Medicare/Medicaid | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| BROAD INSTITUTEScience/Technology, Budget/Appropriations, Medical/Disease Research/Clinical Labs, Defense | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| VERTEX PHARMACEUTICALS INCORPORATEDHealth Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Trade (domestic/foreign) | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| KLASKO IMMIGRATION LAW PARTNERS, LLP ON BEHALF OF INTEALTHHealth Issues, Immigration, Homeland Security | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| EISAI, INC.Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign) | CROSSROADS STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this lobbyist reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
No contribution report we hold lists a gift from this filer.
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.